Doximity, Inc. ( DOCS ) reported a 2Q26 non-GAAP EPS of $0.45. It's a figure that beat estimates by about $0.07. Revenue also came in above expectations, beating consensus by $10.91 with a figure of $168.5 million. Revenue was also up 23.2% year-over-year. TheI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scien ...